A 32 year-old woman with relapsed/refractory stage IV PMBCL with mediastinal tumor complicated with brain metastases…
Cancer History:
First diagnosis of cancer: 02/2018 Cancer type: PMBCL; stage IV
First recurrence date: 08/2018 sites: left inferior frontal lobe 35*30mm, left lung
Refractory or persistent disease sites: left inferior frontal lobe, left lung, severe CNS symptoms (headache)
Therapy gone through: Surgery: No
Chemotherapy 5 cycles, R-DA-EPOCH ; radiotherapy: no
Targeted drugs: no immunotherapy: no others: no
Clinical Trial Number: NCT03125577; enrolled date: 18/09/2018
Interventions: 4SCART (targeting CD19, CD30, CD22), IV after lymphodepletion with Flu-Cy
Consolidation: 4SCART (targeting PSMA)
CRS Grade: 0-1; other side effects: diarrhea, headache, and mild fever around 37.5℃
Treatment response: CR Quality of Life: improved
Progression-free interval: 1 year
Current status: No evidence of disease
Disease images before and after CART (with time)
Link of published paper, youtube, patient’s feedback letter: in preparation
Copyright © 2016 Shenzhen Genoimmune Medical Institute all rights reserved.